agilon health, inc. (NYSE:AGL) Stock Position Trimmed by Bleakley Financial Group LLC

Bleakley Financial Group LLC cut its position in agilon health, inc. (NYSE:AGL) by 59.4% during the 3rd quarter, HoldingsChannel reports. The firm owned 10,649 shares of the company’s stock after selling 15,561 shares during the quarter. Bleakley Financial Group LLC’s holdings in agilon health were worth $42,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after buying an additional 371,537 shares during the period. AQR Capital Management LLC boosted its holdings in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC boosted its holdings in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares during the period. Capital International Investors boosted its holdings in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares during the period. Finally, Simplicity Wealth LLC boosted its holdings in shares of agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after purchasing an additional 15,515 shares during the period.

Analyst Ratings Changes

A number of research firms have issued reports on AGL. Benchmark reiterated a “buy” rating and issued a $9.00 target price on shares of agilon health in a research note on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 target price on shares of agilon health in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Evercore ISI lowered their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Finally, Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a report on Wednesday, October 2nd. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $8.03.

Insider Activity

In other news, CEO Steven Sell purchased 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 3.20% of the company’s stock.

agilon health Stock Performance

Shares of agilon health stock opened at $2.69 on Friday. The business has a fifty day simple moving average of $3.71 and a two-hundred day simple moving average of $5.18. agilon health, inc. has a 1 year low of $2.65 and a 1 year high of $19.00. The company has a market capitalization of $1.11 billion, a price-to-earnings ratio of -3.86 and a beta of 0.54. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter last year, the business earned ($0.04) earnings per share. agilon health’s revenue was up 38.7% on a year-over-year basis. Research analysts forecast that agilon health, inc. will post -0.32 EPS for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.